Cases & Deals

  • Home
  • Practices
  • Myriad acts in High Court's first consideration of genetic material patents

Share

Myriad acts in High Court's first consideration of genetic material patents

October 2015

Client(s) Myriad Genetics, Inc.

Jones Day acted for Myriad Genetics, Inc. in a landmark Australian case before the High Court of Australia. The case represents the first time an Australian court considered the patentability of genetic material, a case in which Jones Day also acted before the U.S. Supreme Court.

D’Arcy v. Myriad Genetics Inc [2015] HCA 35

Contacts

Before sending, please note:

Information on www.jonesday.com is for general use and is not legal advice. The mailing of this email is not intended to create, and receipt of it does not constitute, an attorney-client relationship. Anything that you send to anyone at our Firm will not be confidential or privileged unless we have agreed to represent you. If you send this email, you confirm that you have read and understand this notice.